home / stock / cnsp / cnsp news

CNSP News and Press, CNS Pharmaceuticals Inc. From 12/23/20

Stock Information
Company Name: CNS Pharmaceuticals Inc.
Stock Symbol: CNSP
Market: NASDAQ
Website: cnspharma.com
Menu
CNSP CNSP Quote CNSP Short CNSP News CNSP Articles CNSP Message Board
Get CNSP Alerts

News, Short Squeeze, Breakout and More Instantly...
CNSP - CNS Pharmaceuticals sinks after pricing equity offering of $10M

Small-cap CNS Pharmaceuticals (CNSP) drops 12% after pricing of an underwritten public offering of 5M shares and warrants to purchase up to 2.5M shares of common stock, at combined price of $2/share & warrant.Five-year warrants will have an exercise price of $2.20/share.Underwri...
CNSP - CNS Pharmaceuticals Announces Pricing of $10.0 Million Public Offering

CNS Pharmaceuticals Announces Pricing of $10.0 Million Public Offering PR Newswire HOUSTON , Dec. 23, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of ...

CNSP - CureVac, fuboTV leads premarket losers' pack

Cellectar Biosciences CLRB -22% after it intends to offer and sell shares of its common stock in a public offering.Kubient KBNT -13% after prices equity offering at $5.10.Big Rock Partners Acquisition (BRPA) -13%.Voyager Therapeutics VYGR -11% afte...

CNSP - QuantumScape (QS), Washington Prime Group (WPG), Aurora Mobile (JG) and Ocugen (OCGN) among midday movers

Gainers: Ocugen (OCGN) +114%.Big Rock Partners Acquisition (BRPA) +110%.Aurora Mobile (JG) +50%.Aqua Metals (AQMS) +45%.NantHealth (NH) +39%.Sportsman's Warehouse Holdings (SPWH) +37%.Aemetis (AMTX) +30%.Foresight Autonomous Holdings (FRSX) +29%.QuantumScape (QS) +28%.Cyclacel Pharmaceut...
CNSP - Ocugen, NantHealth leads healthcare gainers; Soligenix, SOS among major losers

Gainers: Ocugen (OCGN) +90%, NantHealth (NH) +35%, Organovo (ONVO) +25%, Genprex (GNPX) +23%, Spero Therapeutics (SPRO) +14%.Losers: Soligenix (SNGX) -54%, SOS (SOS) -39%, Venus Concept (VERO) -23%, BioCryst Pharmaceuticals...

CNSP - EyeGate Pharmaceuticals, Editas Medicine leads healthcare gainers; Scopus BioPharma, uniQure among major losers

Gainers: EyeGate Pharmaceuticals (EYEG) +78%, Editas Medicine (EDIT) +42%, NantKwest (NK) +30%, Liminal BioSciences (LMNL) +29%, Agios Pharmaceuticals (AGIO) +24%.Losers: Scopus BioPharma (SCPS) -17%, uniQure (QURE) -16%, C...

CNSP - Mereo BioPharma, Cyclo Therapeutics leads healthcare gainers; Mesoblast, Virios Therapeutics among major losers

Gainers: Mereo BioPharma (MREO) +91%, Cyclo Therapeutics (CYTH) +44%, Petros Pharmaceuticals (PTPI) +29%, CNS Pharmaceuticals (CNSP) +17%, Humanigen (HGEN) +17%.Losers: Mesoblast (MESO) -34%, Virios Therapeutics (VIRI) -30%, BioCardia (BCDA) -...
CNSP - Healthcare tops premarket gainers list

CNS Pharmaceuticals (CNSP) +62%.Cyclo Therapeutics (CYTH) +47%.Mereo BioPharma Group (MREO) +38% on licensing pact with Ultragenyx.DermTech (DMTK) +23% after announcing topline results from its TRUST Study of the company’s non-invasive melanoma rule-out test, the Pigmented Le...

CNSP - CNS Pharma to discuss IND approval and Phase 2 trial for berubicin today, shares up 77%

CNS Pharmaceuticals (CNSP) will host a conference call and live webcast today at 8:30 am ET to discuss its Investigational New Drug ((IND)) approval for Berubicin, for the treatment of Glioblastoma Multiforme ((GBM)), and planned Phase 2 Berubicin clinical trial. By the end of the Q1 2021, CN...

CNSP - CNS Pharmaceuticals Announces Call to Discuss FDA IND Approval and Phase 2 Trial for Berubicin

CNS Pharmaceuticals Announces Call to Discuss FDA IND Approval and Phase 2 Trial for Berubicin HOUSTON , Dec. 17, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the developme...
Previous 10 Next 10